CRISPR Therapeutics AG (CRSP) Stock | CRSP Stock Price & Analysis

Overview

My Notes

Začít psát

Community Notes

There are no posts to show right now.

CRSP Fair Price

$15.25

Undervalued by 74.6%

To display the fair price of a share, you need to be a member of Bulios Black.

Middleweight #03

$CRSP

Healthcare

To display the Bulios Octagon Score, you need to be a member of Bulios Black.

Profile Equity Nasdaq

CRISPR Therapeutics AG is a Swiss biotechnology company specializing in the development of therapeutics based on the revolutionary CRISPR-Cas9 technology. This technology enables precise and efficient editing of genetic material, opening up new possibilities in treating genetic diseases and other conditions. CRISPR Therapeutics focuses its research on the treatment of various genetic disorders, including beta-thalassemia and muscular dystrophy. The company collaborates with renowned scientific institutions and experts to strengthen its research and develop new therapeutic approaches. CRISPR Therapeutics AG is an innovative player in the biotechnology industry and is committed to bringing revolutionary treatments to patients with genetic diseases. CRISPR Therapeutics AG (CRSP) shares represent an attractive investment opportunity for investors who follow the biotechnology sector and seek an innovative company engaged in treating genetic disorders.

person CEO

Dr. Samarth Kulkarni Ph.D.

psychology Sector

Healthcare

factory Industry

Biotechnology

people Employees

407

people Website

crisprtx.com

flag Country

location_city City

Zug

Basic 5.54B

Market Cap

5.54B

Shares Out

84.92M

Revenue

270.50M

Volume

1.77M

Volume Avg

1.33M

Valuation -24.17

P/E

-24.17

P/B

2.45

P/S

19.56

D/E

0.11

D/C

0.10

EPS

-2.70

Returns -8.90%

ROA

-8.90%

ROE

-11.56%

ROIC

-12.97%

Margins -80.27%

Gross

48.30%

Operating

-110.40%

Net

-80.27%

FCF

-3.15%

Dividends -

Yield

Payout

DPS

CRISPR Therapeutics AG

CRSP

My Notes

Community Notes

What is Fair Price?

What is Bulios Octagon Score (BOS)?

Market Cap

Shares Outstanding

Revenue

Volume

Volume Avg

Price Earnings

Price To Book

Price To Sales

Debt To Equity

Debt To Capital

Earnings Per Share

Return On Assets

Return On Equity

Return On Invested Capital

Gross Profit Margin

Operating Profit Margin

Net Profit Margin

Free Cash Flow

Yield

Payout

DPS (Dividend Per Share)

CRISPR Therapeutics AG

CRSP

My Notes

Community Notes

Market Cap

Shares Outstanding

Revenue

Volume

Volume Avg

Price Earnings

Price To Book

Price To Sales

Debt To Equity

Debt To Capital

Earnings Per Share

Return On Assets

Return On Equity

Return On Invested Capital

Gross Profit Margin

Operating Profit Margin

Net Profit Margin

Free Cash Flow

Yield

Payout

DPS (Dividend Per Share)

Create Bulios profile

Create your profile and choose stocks like a pro with Bulios analysis and tools

Why Bulios?

Log in to Bulios

Log in and follow your favorite stocks, create a portfolio and discuss with others